Cargando…
Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors
Hormone-dependent cancers exhibit high morbidity and mortality. In spite of advances in therapy, the treatment of hormone-dependent cancers remains an unmet health need. The tumor microenvironment (TME) exhibits unique characteristics that differ among various tumor types. It is composed of cancerou...
Autores principales: | Tzanakakis, George, Giatagana, Eirini-Maria, Kuskov, Andrey, Berdiaki, Aikaterini, Tsatsakis, Aristidis, Neagu, Monica, Nikitovic, Dragana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563227/ https://www.ncbi.nlm.nih.gov/pubmed/32847060 http://dx.doi.org/10.3390/cancers12092401 |
Ejemplares similares
-
Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy
por: Berdiaki, Aikaterini, et al.
Publicado: (2021) -
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis
por: Tzanakakis, George N., et al.
Publicado: (2021) -
The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican
por: Berdiaki, Aikaterini, et al.
Publicado: (2023) -
Lumican in Carcinogenesis—Revisited
por: Giatagana, Eirini-Maria, et al.
Publicado: (2021) -
Proteoglycans—Biomarkers and Targets in Cancer Therapy
por: Nikitovic, Dragana, et al.
Publicado: (2018)